Full text is available at the source.
Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects
Nicotinamide Mononucleotide Reduces Lung Injury Caused by LPS Through Anti-Inflammatory, Antioxidant, and Cell-Protection Effects
AI simplified
Abstract
Nicotinamide mononucleotide (NMN) significantly improved lung health in a mouse model of acute lung injury induced by lipopolysaccharide.
- NMN treatment reduced pathological damage and cell death in lung tissue compared to the LPS group.
- Levels of inflammatory cytokines TNF-α, IL-1β, and IL-6 in bronchoalveolar lavage fluid were decreased with NMN administration.
- The total cell count and neutrophil count in bronchoalveolar lavage fluid were lower in the NMN-treated group.
- NMN lowered the dry-to-wet ratio and malondialdehyde (MDA) content, indicators of lung injury.
- Phosphorylation levels of p38 MAPK and p65 NF-κB were reduced with NMN treatment, suggesting decreased inflammation.
- Superoxide dismutase (SOD) activity was increased following NMN treatment, indicating enhanced antioxidative response.
AI simplified